About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,621 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,621 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5441-5460 of 6,621 trials

CompletedBelinostat in Relapsed or Refractory Peripheral T-Cell LymphomaThe purpose of this study is to assess efficacy and safety of belinostat in participants with relapsed or refractory peripheral T-cell lymphoma (PTCL), who failed at least one…NCT00865969·Duarte, California and 116 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

UnknownR-CMOP in Patients With Primary Diffuse Large B-cell LymphomaTo evaluate the efficacy and safety of R-CMOP regimen based on mitoxantrone hydrochloride liposome injection in the treatment of newly diagnosed diffuse large B-cell lymphoma…NCT05777369

CompletedA Study of Long-Term Rituximab (MabThera) Maintenance Therapy in Participants With Advanced Follicular LymphomaThis study will evaluate the efficacy, safety, and tolerability of long-term maintenance therapy with rituximab in participants with advanced follicular lymphoma who have had a…NCT02569996·Budapest and 20 others

UnknownA Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell LymphomaThis study is a multi-center, open-label, single-arm phase I clinical study of LP-108.NCT04356846·Nanjing, Jiangsu

CompletedPhase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated DonorThe purpose of this research study is:(1) to determine if high doses of chemotherapy without total body irradiation can allow selected stem cells to take and grow,(2) to determine…NCT00582933·New York, New York

TerminatedChemotherapy for Relapsed Epstein Barr Virus Associated LymphomaBy combining a variety of agents that potentiate Zidovudine (ZDV), the investigators hope to induce remission in this generally fatal disease.NCT01964755·Miami, Florida and 1 other

TerminatedVaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's LymphomaRATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill cancer cells.NCT00006478·Omaha, Nebraska

Active not recruitingStudy to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog AlfaThis is a multinational, prospective, open-label, roll-over study in patients with haemophilia A, ≥6 years of age, who have completed participation in any of the parental studies…NCT06716814·Plovdiv and 19 others

CompletedA Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic FunctionThe purpose of this study is to characterize the pharmacokinetics (what the body does to the study medication) of JNJ-38518168 at approximately steady-state (stable medication…NCT01863784·Orlando, Florida and 2 others

Active not recruitingActivated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)Patients have a type of lymph gland cancer called Non-Hodgkin Lymphoma (NHL), acute lymphocytic leukemia (ALL) or chronic lymphocytic leukemia (CLL) (these diseases will be…NCT02050347·Houston, Texas and 1 other

Active not recruitingClinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic CancerBackground: * Individuals may be prone to develop blood or lymph node cancers (leukemia or lymphoma) for a variety of reasons, including genetic predisposition to these cancers…NCT00039676·Bethesda, Maryland and 1 other

UnknownASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell LymphomaThe primary objective of the the trial is to establish one of three study arms, as future standard based on the comparison of the investigator-assessed failure-free survival.NCT02858258·Aalborg and 111 others

UnknownBortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011)This is a phase I/II trial of bortezomib, cladribine, and rituximab in newly diagnosed and relapsed mantle cell lymphoma (MCL).NCT01439750·Hershey, Pennsylvania and 1 other

CompletedBortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaThis phase I trial is studying the side effects and best dose of bortezomib when given together with fludarabine with or without rituximab in treating patients with relapsed or…NCT00068315·Canton, Ohio and 6 others

UnknownTrial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell LymphomaThe purpose of this study is to investigate efficacy and safety of R-GemOx Versus R-miniCHOP as first-line treatment of elderly patients with Diffuse large B cell lymphomaNCT02767674·Wuhan, Hubei and 5 others

RecruitingBuddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family CaregiversThe global cost of dementia is over 818 billion, and a further rise is expected in the next decade.NCT06584110·Hong Kong

CompletedIntra-Osseous Co-Transplant of UCB and hMSCThis clinical trial studies intra-osseous donor umbilical cord blood and mesenchymal stromal cell co-transplant in treating patients with hematologic malignancies.NCT02181478·Cleveland, Ohio

UnknownA Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's LymphomaThis is a single-arm, open label, dose escalation, phase I study of C-CAR039 in adults with relapsed/refractory B-cell Non-Hodgkin's Lymphoma.NCT04693676·Hangzhou, Zhejiang

CompletedSERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)An 18 months randomised double-blind study with two parallel arms with start dose of inhaled SERETIDE 50/100mcg BD or FLIXOTIDE 100mcg BD, Phase I is 6 months where the patient…NCT00455923·Luleå

CompletedChemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00020943·Anniston, Alabama and 80 others

PreviousPage 273 of 332Next